DYSLIPIDEMIA IN OBESITY: UNRAVELING MECHANISMS AND IMPLICATIONS FOR CHRONIC NONCOMMUNICABLE DISEASES MANAGEMENT.

Abstract

Background: The current study is conducted to evaluate therapeutic strategies for dyslipidemia linked with obesity. Noncommunicable chronic diseases (CNCDs) have emerged as a predominant health challenge, influenced by various factors such as genetics, congenital conditions, autoimmunity, and idiopathic causes. This essay aims to elucidate the characteristics of CNCDs, particularly focusing on dyslipidemia's association with obesity. CNCDs, characterized by their non-transmissible nature, are among the leading causes of mortality. Lifestyle modifications, including diet and physical activity, are primary interventions. However, contemporary lifestyles, marked by sedentarism and poor dietary habits, exacerbate the risk factors associated with these diseases.

Methodology: An argumentative research derived from a compilation and review of bibliographic sources sourced from databases like PubMed, Scielo, WHO, MSP, Elsevier, Science Direct, Dialnet, and others. A total of 11 articles in English and Spanish were selected based on their relevance and recency.

Contributions to my information: The paper underscores the criticality of healthy lifestyles in mitigating CNCD risks and introduces essential terms and concepts pivotal for medical training.

Conclusions: CNCDs, characterized by their chronic nature and widespread prevalence, necessitate urgent interventions. Dyslipidemia, especially when associated with obesity, presents substantial health challenges. Emphasizing lifestyle modifications, complemented by pharmacological interventions like statins, offers a promising approach to manage and mitigate these health risks.